Indian markets experienced significant profit booking, falling over a percent amidst a weak global trend. According to The Economic Times, key stocks like Vedanta, Honasa Consumer, IRCTC, Bajaj Auto, and Infosys are in focus due to significant developments. Vedanta saw a major promoter stake sale, while Honasa Consumer plans an acquisition and Bajaj Auto reported a ransomware attack. Additionally, IRCTC's CMD resigned, highlighting the mixed corporate developments affecting market sentiment.
From a technical standpoint, the Nifty has largely retraced its previous decline, while Bank Nifty has completely engulfed the previous session's dip. As reported by Business Standard, the outperformance of banking stocks and the rebound from a crucial support zone reinforce the strength of the prevailing uptrend. However, the Nifty needs to decisively surpass the 24,150–24,200 zone before resuming its gradual move towards the 24,500–24,600 range. On the downside, support remains intact in the 23,750–23,650 zone, with consolidation in the index appearing more likely in the near term.
Delhivery is recommended as a buy with a current price of ₹481.05 and a target of ₹515 with a stop-loss at ₹462. According to Ajit Mishra's analysis from Religare Broking, after a prolonged phase of underperformance following its listing gains in July 2022, Delhivery stock has been consolidating and building a broad base near the lower end of its corrective phase. The stock has formed an Inverse Head and Shoulders pattern, a widely recognised bullish reversal structure that typically develops after an extended downtrend, while simultaneously reclaiming its key weekly moving averages.
Aurobindo Pharma is recommended as a buy with a current price of ₹1,530.6 and a target of ₹1,635 with a stop-loss at ₹1,475. As reported by Religare Broking, Aurobindo Pharma has recently confirmed an upside breakout from a flag formation, a bullish continuation pattern signaling strengthening momentum. Price remains above key short-to-medium-term moving averages, while expanding volume confirms sustained buying interest, with recent recovery from lower levels indicating buyers are regaining control with improving confidence.
The corporate landscape is witnessing significant consolidation moves, with Honasa Consumer acquiring a majority stake in nutraceuticals brand Fluence Pharma for ₹135 crore. This strategic move, Honasa's second acquisition in under a year, signals a growing trend of consolidation in the beauty and personal care sector. MoEngage has acquired AI startup Aampe, bolstering its artificial intelligence capabilities, with MoEngage cofounder and chief executive Raviteja Dodda stating the company is evaluating more inorganic growth opportunities, particularly in markets such as the US and Europe. Additionally, EMA Partners India acquired Taggd for ₹95 crore in an all-cash deal, integrating executive search with AI-powered RPO to create a comprehensive talent recruitment platform.
